Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Leases (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Operating Leases for 6 consecutive years, with $110374.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 53.5% year-over-year to $110374.0, compared with a TTM value of $110374.0 through Dec 2025, down 53.5%, and an annual FY2025 reading of $143148.0, down 26.36% over the prior year.
  • Operating Leases was $110374.0 for Q4 2025 at Neuroone Medical Technologies, down from $143148.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $284235.0 in Q1 2021 and bottomed at $20982.0 in Q4 2023.
  • Average Operating Leases over 5 years is $181168.8, with a median of $202895.0 recorded in 2021.
  • The sharpest move saw Operating Leases tumbled 92.3% in 2023, then skyrocketed 1031.34% in 2024.
  • Year by year, Operating Leases stood at $173314.0 in 2021, then soared by 57.17% to $272405.0 in 2022, then crashed by 92.3% to $20982.0 in 2023, then surged by 1031.34% to $237377.0 in 2024, then tumbled by 53.5% to $110374.0 in 2025.
  • Business Quant data shows Operating Leases for NMTC at $110374.0 in Q4 2025, $143148.0 in Q3 2025, and $175344.0 in Q2 2025.